EV Biologics Market Cap

EV Biologics has a market cap or net worth of $840.53 thousand as of March 9, 2026. Its market cap has decreased by -91.25% in one year.

Market Cap

840.53K

Enterprise Value

n/a

Revenue

9.47M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.08

Market Cap Chart

Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 840.53K, a decrease of -98.81%. That is a compound annual growth rate of -34.00%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2026	840.53K	1.36%
Dec 31, 2025	829.28K	-15.08%
Dec 31, 2024	976.52K	-90.45%
Dec 20, 2023	10.23M	-56.18%
Dec 28, 2022	23.33M	109.88%
Dec 31, 2021	11.12M	-83.80%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Protagenic Therapeutics	811.84K
Avenue Therapeutics	724.82K
Lipella Pharmaceuticals	716.69K
SQZ Biotechnologies Company	707.79K
Emmaus Life Sciences	1.02M
CERo Therapeutics Holdings	1.02M
Scorpius Holdings	672.57K
Eastgate Biotech	1.06M

Market Cap Rankings